Ian Walters
Directeur Général chez PORTAGE BIOTECH INC.
Fortune : 123 906 $ au 30/04/2024
Postes actifs de Ian Walters
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PORTAGE BIOTECH INC. | Président | 18/08/2022 | - |
| Directeur Général | 06/05/2019 | - | |
| Directeur/Membre du Conseil | 01/08/2016 | 18/08/2022 | |
| Independent Dir/Board Member | 01/08/2016 | 06/05/2019 | |
| ENZO BIOCHEM, INC. | Directeur/Membre du Conseil | 25/11/2020 | - |
| Independent Dir/Board Member | 25/11/2020 | - | |
iOX Therapeutics Ltd.
 iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 01/07/2015 | - |
Stimunity SAS
 Stimunity SAS BiotechnologyHealth Technology Stimunity SAS provides biotechnology services. The company is based in Paris, France. The French company was founded in 2016 by Sylvain Carlioz, Nicolas Manel. Sylvain Carlioz has been the CEO since 2016. | Président | - | - |
SalvaRx Ltd.
 SalvaRx Ltd. BiotechnologyHealth Technology SalvaRx Ltd. develops and provides treatment in the field of cancer immunology. The company is headquartered in London, the United Kingdom. | Directeur Général | - | - |
Historique de carrière de Ian Walters
Anciens postes connus de Ian Walters
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/08/2014 | 01/08/2023 |
| SALVARX GROUP PLC | Directeur/Membre du Conseil | 01/01/2007 | 08/01/2019 |
| Directeur Général | 01/01/2007 | 08/01/2019 | |
| Fondateur | 01/01/2007 | 08/01/2019 | |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Directeur des opérations | 01/01/2007 | 01/03/2014 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | - | - |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Ian Walters
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 9 |
| Royaume-Uni | 5 |
| Canada | 2 |
Opérationnelle
| Director/Board Member | 6 |
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 12 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| PORTAGE BIOTECH INC. | Health Technology |
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| ENZO BIOCHEM, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 8 |
|---|---|
SalvaRx Group Plc
 SalvaRx Group Plc BiotechnologyHealth Technology SalvaRx Group Plc engages in the development of drug that focuses on cancer immune-oncology. Its products portfolio includes iOx therapeutics, intensity therapeutics, nekonal oncology, and rift biotherapeutics. The company was founded by Ian B. Walters and Robert A. Kramer in 2007 and is headquartered in Ramsey, Isle of Man. | Health Technology |
3Legs Resources Plc
 3Legs Resources Plc Financial ConglomeratesFinance 3Legs Resources Plc engages in the provision of investing in acquire companies within the technology sector. It includes interest in a proposed investment and acquisition. The company was founded on July 22, 2002 and is headquartered in Ramsey, Isle of Man. | Finance |
RIFT biotherapeutics, Inc.
 RIFT biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services RIFT biotherapeutics, Inc. operates as a therapeutic antibody company that focuses on immuno-oncology targets outside of the T-cell space. It generates therapeutic antibodies that harness the immune system, to target cancers in areas of unmet needs. The company was founded by Miguel A. de los Ríos, Cornelia Bentley, and Jeff Pitman in 2015 and is headquartered in San Diego, CA. | Commercial Services |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Health Technology |
iOX Therapeutics Ltd.
iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Stimunity SAS
Stimunity SAS BiotechnologyHealth Technology Stimunity SAS provides biotechnology services. The company is based in Paris, France. The French company was founded in 2016 by Sylvain Carlioz, Nicolas Manel. Sylvain Carlioz has been the CEO since 2016. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
SalvaRx Ltd.
SalvaRx Ltd. BiotechnologyHealth Technology SalvaRx Ltd. develops and provides treatment in the field of cancer immunology. The company is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Ian Walters
- Expérience